Abstract Purpose: To evaluate the anti-cancer activity of Indonesian Pasuruan propolis extract (PPE) against HT-29 human colon carcinoma cell line.
INTRODUCTION
Colorectal cancer (CRC) contributed the third highest cancer prevalence in men and the second highest in women worldwide. Despite advanced diagnosis and therapy in recent years, its prevalence is rising, and the 5-years survival rate remains poor. CRC has become a serious healthcare problem in most Asian countries including China, South Korea, Japan, and Singapore, with a 2 to 4-fold increase in its incidence in 2004-2014 [1] . More efficacious It has been reported that the inactivity of p53 protein is possibly leads to TP53 gene mutation. p53 mutation occurs in approximately 40-50 % of sporadic CRC. CRC patients with mutant p53 appear to be more chemo-resistant and have poorer prognosis than those with the wild-type [2] . This protein protecting genome from changes as the result of DNA damage by stopping cell cycle and inducing the activation of cell repair mechanisms, as well as cell death [3] . The activation of p53 protein by stress factors will enter into the mitochondria to activate the expression of pro-apoptotic genes, as well as inhibits the expression of anti-apoptotic genes, such as those of the Bcl family -2 (Bcl-2, Bcl-X, Bcl-in, Mcl-1) [3] .
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Propolis is collected by bees from tree exudates primarily resins of leaf bud and other botanical sources. [4] . Propolis has been commonly used as traditional medicine due to its broad spectrum of biological activities, namely anti-cancer, antioxidant, anti-inflammation, and antibiotic activities [4] [5] [6] . Previous studies found that Indonesian propolis showed significant anticancer activity when administered in some cancer cell lines beside HT-29 [6] [7] [8] . This research aimed to observe the effect of Indonesian Pasuruan propolis extract (PPE) against HT-29 human colon carcinoma cell line by inhibiting the cell cycle and promoting the expression of apoptotic markers including p53, Ki67, cyclin D1 and Bcl-xL.
EXPERIMENTAL Propolis and extraction
Propolis was collected manually from beehives of Trigona sp. located in Pasuruan (East Java, Indonesia). Prior to the extraction, propolis which has been cleaned was crushed, and placed in an opaque and closed container. The sample (100 g) was extracted with 900 mL of ethanol at room temperature for 14 days. The obtained solution was filtered and re-extracted twice under the same condition, then evaporated to remove ethanol. PPE was dissolved in dimethylsulfoxide (DMSO) and adjusted to a working concentration with culture medium (DMSO concentration was 0.1 %) and then stored at 4 °C until used for treatment.
Determination of PPE content
The content of PPE was analyzed through liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS), consisting of a liquid chromatograph (Shimadzu, Japan) connected to Mass Spectrometer QTRAP 3200 (Applied Biosys-tems, USA). Moreover, the chromatographic separation was conducted using RP-C18 Column Inertsil ODS-3 (2.1 x 150 mm, 3 mm). The elution was conducted by using 0.1 % formic acid as solvent A and methanol as solvent B at 35 °C. Data acquisition was performed using software Analyst 1.5.1 (Applied Biosystems, USA). The specific parameters for the Multiple Reaction Monitoring (MRM) experiment in positive and negative polarity were optimized using as standards caffeic acid phenethyl ester (CAPE), artepillin C, quercetin, apigenin, chrysin, and kaempferol.
Cell line culture
HT-29 human colon carcinoma cell line was obtained from the American Type Culture Collection (ATCC, Manassas, VA). Cells were cultured in McCoy's 5A culture medium (SigmaAldrich, MO, USA) supplemented with 10% Fetal Bovine Serum (Gibco, Invitrogen, USA) and 1% penicillin-streptomycin (Invitrogen, USA). The cells were grown at 37 °C in a humidified atmosphere of 5% CO 2 and were routinely subcultured using 0.25 % (w/v) trypsin-EDTA solution.
Flow cytometry analysis
Cells were cultured in 24-well plates in concentration of 1 x 10 6 cells/well. Cells were treated with 50, 100, 200 and 400 μg/mL PPE for 24 h after reaching 70-80 % of cell confluence.
Prior to PPE treatment, the cells were labelled with 10 μM carboxysuccinimydil ester (CFSE)(Santa cruz, CA, USA) for 30-60 min. After being labelled, the medium was removed and replaced with fresh complete medium and the test compounds (PPE) were added in the desired concentrations and incubated for 24 h. At the end, cells were collected, then washed twice in phospate buffer saline (PBS), and incubated in 5 μg/mL propidium iodide (PI) for 15 min at 4 °C in the dark. CFSE and/or PI-positive cells were determined by flow cytometry (FACSCalibur TM; Becton Dickinson).
Apoptosis detection
The cell mortality rate was determined through flow cytometry using Annexin V-FITC apoptosis detection kit according to the manufacturer's instructions (BD Bioscience, USA). Cells were washed twice in 300 μL cell staining buffer (CSB) (Biocare Medical) and centrifuged at 2500 rpm for 3 min at 4 °C. The pellets were incubated in Immunocytochemistry for p53, Ki67, Cyclin D1 and Bcl-xL expressions Cells (1 x 10 5 cells/well) were grown for 24 h on glass coverslips. PPE treatment was given at concentrations of 50, 100, 200 and 400 μg/mL for 24 h. Briefly, cells were fixed in 100 % methanol and washed twice with PBS. Incubation with monoclonal antibody against Ki67, p53 tumor suppressor protein (Biocare Medical) by 1:100 dilution, Cyclin D1, and Bcl-xL (Santa cruz, CA, USA) by 1:100 dilution were carried out overnight at 4 °C. This step was followed by incubation with FITC-conjugated secondary antibody (Biocare Medical) for 1 h at room temperature, followed by Streptavidin-HRP, Diaminobenzidine (DAB), and Meyer incubation. The histology slides were assessed blindly by pathologist. The slides were investigated using light microscope with objective 40X. The percentage of positive cells was measured by counting around 200 cells at four microscope fields that were chosen randomly.
Statistical analysis
The data are expressed as mean + SD. Statistical analysis was performed using SPSS 22 PS software by ANOVA or Kruskall Wallis followed by Least Significant Difference (LSD) post hoc test. Significance level was set at p < 0.05.
RESULTS

PPE composition
Propolis samples from tropical zones, such as Indonesia with its vast biodiversity, have become a subject of increasing scientific and economic attention. The association of propolis investigator concerning in its chemical composition from different geographic regions with biological activities lead to the identification of active principles, a fundamental tool to achieve standardization of this bee product [7] . LC-MS/MS analysis indicated that the PPE contained chrysin, kaempferol, quercetin, and CAPE. The main peaks in the chromatogram 5 were identified using standard samples ( Figure  1 ). 
PPE downregulates p53 in HT-29 cells
The immunocytochemistry investigation of HT-29 shows that PPE treatment inhibited the expression of p53 significantly in dosedependent manner (p = 0.000) (Figure 2) , which is up to 200 µg/mL.
PPE slightly reduced HT-29 cell proliferation
The effect of PPE treatment on cell proliferation was investigated by CFSE marker with flow cytometry. Meanwhile, Ki67 protein expression in HT-29 cells was investigated through immunocytochemistry. It could be seen that PPE treatment inhibited the cell proliferation of HT-29 in concentration dependent manner. However, no obvious changes were observed and were not statistically significant (p = 0.842, Figure 3) . Immunocytochemistry analysis for cell proliferation showed that PPE slightly reduced 
Inhibition of Cyclin D1 protein expression by PPE
HT-29 cells that were treated with PPE in various concentrations (50-200 μg/mL) for 24 h showed slightly lower level of cyclin D1 expressions than its expression in control group. On the other hand, high concentration of PPE (400 μg/mL) significantly decreased cyclin D1 expression (p = 0.149, Figure 5 ).
Apoptosis induction by PPE in a concentration-dependent manner
The apoptotic effect of PPE in different concentrations, the apoptosis was detected by staining with Annexin V and PI staining methods. Cells were treated with PPE (50 -200 μg/mL) showed slight induction of cell apoptosis, whereas cell treated with 400 μg/mL PPE showed reduction of cell apoptotic more than control group (p = 0.416, Figure 6 ). 
PPE inhibits Bcl-xL protein expressions
The determination whether PPE induction of HT-29 cell death cells through the regulation of BclxL protein and anti-apoptotic proteins following PPE treatment were analyzed by flow cytometry. In this study, PPE administration downregulated Bcl-xL expression significantly. However, its expression was significantly increased when treated with 400 μg/mL PPE (p = 0.000, Figure  7 ). 
DISCUSSION
Proliferation plays a pivotal role in the cancer development and progression through the alteration of protein expressions and/or cell cycle related proteins activities [9] . The effect of PPE that indicated its anti-cancer activity by inhibiting proliferation, inducing apoptosis, decreasing expression of p53, Ki67, cyclin D1, and Bcl-xL.
Cyclin D1 is a protein encoded by CCND1 which has been proven to act as an oncogene [10, 11] . It is included in the family of cyclins that has significant role in cell cycle, particularly in G1 transition to S phase. Cyclin D1 was found overexpressed in more than a third of colorectal cancer cases. In spite of the role of cyclin D has been investigated, the relationship between cyclin D1 expression in colon cancer prognosis has not been clearly revealed yet [12] . The present study found that PPE significantly decreased expression of cyclin D1 after treatment with PPE at 400 μg/mL.
In the previous experiment, Li et al showed the effect of the ethanol extract of Brazilian propolis on the metastasis human prostate cancer cells proliferation (DU145 and PC-3) cancer and primary malignant tumor (RC58T/h/SA#4) . The result showed that propolis botanical origin inhibited the growth of RC58T/h/SA#4 through the inhibition of cyclin D1 expression [13] . PPE treatment at dose 50 -400 μg/mL inhibited the proliferation of HT-29 cell significantly. Although, PPE decreased cyclin D1 expression significantly, but this decline caused to insignificant inhibition of cell proliferation.
For confirmation of cell proliferation activity, we performed immunocytochemical tests of Ki67 expression. The expression of Ki67 nuclear antigen was decreased after PPE administration. However, the result was not statistically significant (p > 0.05). This finding is consistent with the result of cell proliferation measurement by flow cytometry. The poor anti-proliferation effect of PPE may indicate that the concentration used should be higher than 400 µg/mL, considering that the active ingredient of propolis varies from each site. In addition, regulation of other cell proliferation-related proteins may be required to achieve maximum results. The significant inhibition of cell growth is resulted from the protein expression regulation of cyclin D1, B1, and cyclin dependent kinase (CDK) as well as p21 [13] .
HT-29 cell has a mutant p53. Here we found that PPE significantly decreased the expression of p53. It has also been demonstrated that the PPE derived from the Chinese that was given to MDA-MB-231 cells possessing mutant p53. The results show reduction level of mutant p53 in a dosedependent manner [9] . Apoptosis is a wellcharacterized type of programmed cell death and is considered a highly regulated process that allows unwanted or dysfunctional cells to selfdegrade [14] . It is found that PPE at dosage of 50 -200 μg/mL induced apoptosis in HT-29 cell in vitro. It has been shown that Indonesian propolis other than PPE also induced cell apoptosis in vitro against other cell lines side HT-29 cells [7, 8] . However, PPE treatment gave insignificant result on inducing apoptosis of HT-29 cells was. This is expected due to the lower level of main active component compared to other propolis.
The mechanism of apoptosis seems to be induced by Bcl-xL protein regulation as the product of the Bcl-2 gene family that inhibits apoptosis [14] . Therefore, the downregulation of Bcl-xL protein leads to Cytochrome C release by the mitochondria that activates caspase cascade to generate apoptosis [14] . The immunocytochemical study revealed that there was significant decrease in Bcl-xL expression in concentration-dependent manner following treatment with PPE at concentrations between 50-200 µg/mL. Our findings suggest that PPE may promote HT-29 cells to apoptosis through Bcl-xL down-regulation. However, it did not cause significant increase in apoptosis which suggests that HT-29 cells apoptosis occurs in independent Bcl-xL mechanism.
Interestingly, higher concentration of PPE at 400 µg/mL increased expression of Bcl-xL protein and decreased apoptosis level. The previous studies explained that propolis has antioxidant effects [13] . PPE may provide antioxidant effects at lower doses and mediate ROS induction leading to cell damage and cell death. It has been previously documented that other natural component, such as curcumin which is known to possess strong antioxidant activity, mediate ROS induction and cause myocardial damage [15] . Another study showed that administration of high doses of propolis can cause cell death due to necrosis [16] .
According to the result of p53 expression conducted by immunocytochemistry, decreasing expression of p53 did not significantly affect the reduction in cell proliferation and enhancement the cell apoptosis. This phenomenon appeared due to the ability of PPE to reduce the expression of mutant p53 without enhances the function of wild type p53 that allows cell proliferation. When mutant p35 was silenced, it would reduce growth of cellular colony in human cancer cells which was because of the induction of apoptosis [16] .
CONCLUSION
PPE reduced the expression of p53, Ki67, cyclin D1, and Bcl-xL but the decline was not strong enough to inhibit proliferation and promote strong apoptosis signal towards HT-29 human colon carcinoma cell line.
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